P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 214 000 KRW -2.28%
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Operating Income Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
â‚©102.2B
CAGR 3-Years
31%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
â‚©369.6B
CAGR 3-Years
-22%
CAGR 5-Years
6%
CAGR 10-Years
9%
SK Bioscience Co Ltd
KRX:302440
Operating Income
-â‚©12B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Operating Income
â‚©137.7B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Income
-â‚©8.1B
CAGR 3-Years
20%
CAGR 5-Years
4%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Operating Income
-â‚©35.8B
CAGR 3-Years
16%
CAGR 5-Years
-21%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Operating Income?
Operating Income
102.2B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Operating Income amounts to 102.2B KRW.

What is PharmaResearch Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
55%

Over the last year, the Operating Income growth was 41%. The average annual Operating Income growth rates for PharmaResearch Co Ltd have been 31% over the past three years , 55% over the past five years .

Back to Top